BRISTOL MYERS SQUIBB CO·4

Feb 3, 4:36 PM ET

YALE PHYLLIS R 4

4 · BRISTOL MYERS SQUIBB CO · Filed Feb 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Bristol Myers (BMY) Director Phyllis R. Yale Receives Award

What Happened
Phyllis R. Yale, a non-employee director of Bristol Myers Squibb (BMY), was granted 3,996.367 deferred share units on Feb 1, 2026. The filing records a notional price of $55.05 per share, for a reported aggregate value of $220,000. This was an award/award-equivalent (transaction code A) of a derivative security (deferred share units), not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-02-01; SEC filing date: 2026-02-03 (filed within the standard 2-business-day window).
  • Award: 3,996.367 Deferred Share Units; per-unit value shown $55.05; total reported value $220,000.
  • Security type: Derivative (Deferred Share Units) that will convert into common stock upon settlement (see footnote).
  • Footnotes: F1 — units convert to shares upon settlement; units become settleable when the director leaves the board or at a previously specified future date. F2 — includes deferred compensation and reinvested dividends under the 1987 Deferred Compensation Plan for Non-Employee Directors.
  • Shares owned after transaction: Not specified in this filing.

Context
Deferred share units are a form of non-cash director compensation and represent a right to receive company stock in the future; they are not immediately tradable shares. Such awards reflect routine board compensation rather than an immediate market signal of insider buying or selling.

Insider Transaction Report

Form 4
Period: 2026-02-01
Transactions
  • Award

    Deferred Share Units

    [F1][F2]
    2026-02-01$55.05/sh+3,996.367$220,00043,326.695 total
    Common Stock, $0.10 par value (3,996.367 underlying)
Footnotes (2)
  • [F1]Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
  • [F2]Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.
Signature
/s/ Amy Fallone, attorney-in-fact for Phyllis R. Yale|2026-02-03

Documents

1 file
  • 4
    wk-form4_1770154603.xmlPrimary

    FORM 4